Half of β-catenin mutated WNT-activated MBs harbor concurrent DDX3X mutations [61], but these mutations are not subgroup-specific: 10–20% of SHH and 3% of Group 3 tumors also carry DDX3X mutations [60]. The gene discussed is SHH; the disease is Mobius syndrome.